SurModics Inc (SRDX)

[Democritus_of_Abdera]

Re: XTENT...

Bridge, I believe that XTENT's product would be a good fit with a company such as WL GORE that focuses upon peripheral arterial disease. Lesions in the tibial and peroneal arteries can be long and narrow....

XTENT would have made a much better fit with Spectronetic's laser arterectomy product than did Nash, which SPNC purchased for its stent program last year. Given the management problems with SPNC, XTENT may be better off with a different partner. The other specialty players in the artherectomy field, CSII or EV3, are not substantially better than SPNC, however.